Wenjiao Li

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 3

Top Topics

Transcription Factor

Dna Methylation

Top Venues

Cancer research communications

Cell death and differentiation

University of Texas MD Anderson Cancer Center

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Texas MD Anderson Cancer Center May 02 2018

United States

Postdoctoral Research Associate :: Department of Genitourinary Medical Oncology

Publications

Stefan Maksimovic, Nina C Boscolo, Ludovica La Posta, Sergio Barrios, Mohammad Jad Moussa, Emanuela Gentile, Pedro I Pesquera, Wenjiao Li, Jianfeng Chen, Javier A Gomez, Akshay V Basi, Jared K Burks, Christopher Alvarez-Breckenridge, Jianjun Gao, Matthew T Campbell, Eleonora Dondossola
Antiangiogenic tyrosine kinase inhibitors have differential efficacy in clear cell renal cell carcinoma in bone. Cancer research communications (2024)
Wenjiao Li, Yuan Dai, Boyun Shi, Fei Yue, Jing Zou, Guibin Xu, Xianhan Jiang, Fen Wang, Xinke Zhou, Leyuan Liu
LRPPRC sustains Yap-P27-mediated cell ploidy and P62-HDAC6-mediated autophagy maturation and suppresses genome instability and hepatocellular carcinomas. Oncogene 39 (19) (2020)
Wenjiao Li, Fei Yue, Yuan Dai, Boyun Shi, Guibin Xu, Xianhan Jiang, Xinke Zhou, Gerd P Pfeifer, Leyuan Liu
Suppressor of hepatocellular carcinoma RASSF1A activates autophagy initiation and maturation. Cell death and differentiation 26 (8) (2018)